GAIN THERAPEUTICS INC
GANX·36269B105·US·Common Stock·Healthcare - Biotechnology
GANX (GAIN THERAPEUTICS INC) is held by 28 institutional investors as of Q1 2026. Largest holders: MARSHALL WACE, LLP ($3.4M), JONES FINANCIAL COMPANIES LLLP ($1.2M), GEODE CAPITAL MANAGEMENT, LLC ($868,527). Net institutional sentiment: Mixed.
28
Holders
Avg rating(7 Elite)
$10.5M
Total Value
45% (39)
Fund Consensus
15 buying - 18 selling
No verdict yet — fewer than 2 funds hold GANX.
13F: Insider & Congress:
Showing 1-20 of 39
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer